Barbara E. Kahn's most recent trade in Dexcom Inc was a trade of 2,927 Common Stock done . Disclosure was reported to the exchange on May 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DexCom | Barbara E. Kahn | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2024 | 2,927 | 22,575 (0%) | 0% | 0 | Common Stock | |
| DexCom | Barbara E. Kahn | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2024 | 2,927 | 0 (0%) | 0% | 0 | Common Stock | |
| DexCom | Barbara E. Kahn | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2023 | 3,976 | 19,648 (0%) | 0% | 0 | Common Stock | |
| DexCom | Barbara E. Kahn | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 May 2023 | 3,976 | 2,927 (0%) | 0% | 0 | Common Stock | |
| DexCom | Barbara E. Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,927 | 6,903 (0%) | 0% | 0.0 | 3 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 994 | 994 (0%) | 0% | 0.0 | 1 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Other type of transaction at price $ 0.00 per share. | 20 May 2022 | 918 | 3,918 (0%) | 0% | 0 | Common Stock | |
| DexCom | Barbara E. Kahn | Director | Other type of transaction at price $ 0.00 per share. | 20 May 2022 | 918 | 0 (0%) | 0% | 0 | Common Stock | |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 434.35 per share. | 10 Feb 2022 | 1,147 | 5,443 (0%) | 0% | 434.4 | 498,205 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 442.18 per share. | 10 Feb 2022 | 476 | 6,590 (0%) | 0% | 442.2 | 210,479 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 443.56 per share. | 10 Feb 2022 | 443 | 5,000 (0%) | 0% | 443.6 | 196,498 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 448.98 per share. | 10 Feb 2022 | 400 | 3,800 (0%) | 0% | 449.0 | 179,590 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 444.80 per share. | 10 Feb 2022 | 400 | 4,600 (0%) | 0% | 444.8 | 177,920 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 452.50 per share. | 10 Feb 2022 | 400 | 3,000 (0%) | 0% | 452.5 | 180,998 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 450.06 per share. | 10 Feb 2022 | 200 | 3,600 (0%) | 0% | 450.1 | 90,013 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 447.35 per share. | 10 Feb 2022 | 200 | 4,200 (0%) | 0% | 447.4 | 89,470 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 445.84 per share. | 10 Feb 2022 | 200 | 4,400 (0%) | 0% | 445.8 | 89,169 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 440.84 per share. | 10 Feb 2022 | 200 | 7,066 (0%) | 0% | 440.8 | 88,169 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 451.28 per share. | 10 Feb 2022 | 200 | 3,400 (0%) | 0% | 451.3 | 90,257 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 438.21 per share. | 10 Feb 2022 | 100 | 7,266 (0%) | 0% | 438.2 | 43,821 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 435.64 per share. | 10 Feb 2022 | 100 | 7,366 (0%) | 0% | 435.6 | 43,564 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 430.06 per share. | 10 Feb 2022 | 100 | 7,466 (0%) | 0% | 430.1 | 43,006 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Sale of securities on an exchange or to another person at price $ 428.55 per share. | 10 Feb 2022 | 100 | 7,566 (0%) | 0% | 428.6 | 42,855 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 918 | 918 (0%) | 0% | 0.0 | 1 | Common Stock |
| DexCom | Barbara E. Kahn | Director | Other type of transaction at price $ 0.00 per share. | 21 May 2021 | 787 | 0 (0%) | 0% | 0 | Common Stock | |
| DexCom | Barbara E. Kahn | Director | Other type of transaction at price $ 0.00 per share. | 21 May 2021 | 787 | 7,666 (0%) | 0% | 0 | Common Stock |